Company: GNMSF
Filing Date: 2025-02-12
Form Type: 20-F
Source: 0001558370-25-000846
Chunk: 99

Company: GENMAB A/S
Filing Date: 2025-02-12
Form: 20-F
Item: Item 5
Chunk 99
---
 become due for future payments in Note 5.3 to our Audited Financial Statements included in our Annual Report 2024 is incorporated herein by reference. The contingent commitments entail uncertainties regarding the period in which payments are due because these obligations are dependent on milestone achievements, most of which are not expected to be incurred within the next five years.
In addition to the above obligations, we enter into a variety of agreements and financial commitments in the normal course of business. The terms generally allow us the option to cancel, reschedule and adjust our requirements based on our business needs prior to the delivery of goods or performance of services. It is not possible to predict the maximum potential amount of future payments under these agreements due to the conditional nature of our obligations and the unique facts and circumstances involved in each particular agreement.
C.   Research and Development, Patents and Licenses, etc.
See “Item 4.B—Business Overview” and “Item 5.A—Operating Results”.
D.   Trend Information
See “Item 5.A—Operating Results—Key Components of Our Results and Related Trends”.
E.  Critical Accounting Estimates
Not applicable.